Roche posts IMpower010 results in resected NSCLC; adds polatuzumab real-world studySep 30Weekly roundup, 9 itemsafimkibartatezolizumabUpdated
Roche's Valium gets label update; trontinemab Alzheimer's trials continue as active, not recruitingSep 25Weekly roundup, 6 itemsChugai PharmaceuticaldiazepamUpdated
Roche posts HCC trial results, registers five new studies across cancer, MS, flu, COPDSep 18Weekly roundup, 6 itemsbaloxavir marboxilcevostamab
Novartis updates Leqvio label; MS study recruiting, thyroid study not yet recruitingAug 21Weekly roundup, 8 itemsGIA632inclisiran
Roche posts results for satralizumab TED trial; completes Ocrelizumab SC vs IV MS studyAug 12Weekly roundup, 2 itemsocrelizumabRoche
Ocrevus higher-dose Phase 3 posts results, misses primary endpoint; two partner trials updateJul 24Weekly roundup, 4 itemsobinutuzumabocrelizumab
Roche posts results for two Phase 3 lebrikizumab asthma trials; Operetta 2 update on pediatric MSJul 17Weekly roundup, 3 itemslebrikizumabocrelizumab
Sign inSign in